ResearcherJohns Hopkins UniversityActive in the last 2 years

Masahiro Maeda

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5125564928. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. Co-author DOI 10.1186/s12943-026-02575-z ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrew P. Feinberg · 1 shared paper, 2026 · strength 0.24
- Paper CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic mo… DOI 10.1186/s12943-026-02575-z ↗
Jimin Min · 1 shared paper, 2026 · strength 0.24
- Paper CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic mo… DOI 10.1186/s12943-026-02575-z ↗
Barbara Stauch Slusher · 1 shared paper, 2026 · strength 0.24
- Paper CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic mo… DOI 10.1186/s12943-026-02575-z ↗
Anirban Maitra · 1 shared paper, 2026 · strength 0.24
- Paper CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic mo… DOI 10.1186/s12943-026-02575-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.